Pharmacokinetics and biomarker analysis from a phase 1/2 open-label study of the anti-GPC3 T-cell engager SAR444200, in patients with advanced solid tumors. Phase 1/2 study of NGM707, an ILT2/ILT4 ...
We review the statistical methods available for carrying out genotype imputation and compare their properties and performance. We also review the downstream uses of imputation, including boosting the ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results